Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in IPO/Stock Watch

Xtalpi, a Quantum Physics-AI Drug Discovery Company, Files for Hong Kong IPO
WuXi XDC Raises $520 Million in IPO; Climbs 39% in First Trading Session
WuXi XDC, an ADC/Bioconjugates CRDMO, Stages $500 Million IPO
QYuns, an Autoimmune/Allergic Disease Biotech, Files for Hong Kong IPO
Adlai Nortye Closes $97.5 Million Nasdaq IPO, Drops 27% Lower in Trading
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital